MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Home Health Management of Parkinson’s Disease Deep Brain Stimulation: A Randomized Clinical Trial

G. Duffley, A. Wright, C. Hess, A. Ramirez-Zamora, P. Zeilman, S. Chiu, A. Szabo, B. Lutz, K. Foote, M. Okun, C. Butson (Salt Lake City, USA)

Meeting: MDS Virtual Congress 2021

Abstract Number: 379

Keywords: Deep brain stimulation (DBS), Parkinson’s

Category: Parkinson’s Disease: Clinical Trials

Objective: Evaluate the efficacy of home health DBS postoperative management in an effort to reduce travel burden and improve access.

Background: The travel required to receive deep brain stimulation (DBS) programming is a substantial burden on patients, and limits those who can access DBS therapy.f

Method: We conducted an open-label, randomized clinical trial at the University of Florida (UF) Health from 2017 to 2020. Consenting participants receiving DBS as part of standard of care treatment for Parkinson’s disease were 1:1 randomized to receive either standard of care (SOC) or home health postoperative DBS management for the first six months after surgery. Primary caregivers, usually the spouse, were also enrolled to assess caregiver strain. The home health postoperative management was conducted by a home health nurse who chose DBS settings with the aid of the iPad based Mobile Application for PD DBS (MAP DBS) system. Prior to the study, the home health nurse had no experience providing DBS care. The primary outcome was the number of times each patient traveled to the movement disorders clinic during the study period. Secondary outcomes included changes from baseline in the Unified Parkinson’s Disease Rating Scale part III (UPDRS III).

Results: A total of 44 patients were enrolled during the study. Twenty-one patients were randomized to SOC DBS and 23 were randomized to home health postoperative management, which included two in person visits and three phone based visits. We analyzed 19 SOC and 23 home health patients who underwent a minimum of one postoperative management visit. The primary outcome revealed that patients randomized to home health had significantly fewer clinic visits than the SOC arm patients (SOC: 4.8 ± 0.4, home health: 0.4 ± 0.8, p < 0.0001). We found no significant differences between the groups in the secondary outcomes measuring the efficacy of DBS. No adverse events were related to the study procedure or devices.

Conclusion: This study provides evidence supporting the safety and feasibility of postoperative, home health DBS management.

MDS 2021 Abstract Table 1

MDS 2021 Abstract Figure 1

MDS 2021 Abstract Table 2

To cite this abstract in AMA style:

G. Duffley, A. Wright, C. Hess, A. Ramirez-Zamora, P. Zeilman, S. Chiu, A. Szabo, B. Lutz, K. Foote, M. Okun, C. Butson. Home Health Management of Parkinson’s Disease Deep Brain Stimulation: A Randomized Clinical Trial [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/home-health-management-of-parkinsons-disease-deep-brain-stimulation-a-randomized-clinical-trial/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/home-health-management-of-parkinsons-disease-deep-brain-stimulation-a-randomized-clinical-trial/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley